quien no puede usar tirzepatide Llega tirzepatida, que reducir hasta casi 20 centímetros el perímetro abdominal en personas con obesidad quien no puede usar tirzepatide

Months 9-12: Approaching Maintenance (2.4 mg dose) Average weight loss: 13-15% cumulative by month 12 (26-30 pounds for a 200-pound person) Around month 6-7 (week 20-24), youll reach the maximum maintenance dose of 2.4 mg weekly

A Board-Certified Weight Loss Specialist Explains Tirzepatide is the active ingredient in the brand-name medication Mounjaro, which is FDA-approved for the treatment of type 2 diabetes

Discover how this preservative-based solution ensures safe multi-dose use in clinical and research settings

When you arrive at our clinic, we begin with a brief consultation to review your medical history and discuss your wellness goals

Find Out More